urinary tract infection. urinary tract infection,site not specified
Conditions
Interventions
Intervention 1: cateterized intensive care unit patients recieved placebo 500 mg /daily for ten day. Intervention 2: ( control group) caterized intensive care unit patients recived one placebo capsule
Prevention
cateterized intensive care unit patients recieved placebo 500 mg /daily for ten day
( control group) caterized intensive care unit patients recived one placebo capsule500 mg for ten day
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: nclusion :hospitalized in intensive care for at least 48 hours- the use of urinary catheter under circumstances prescribed by your doctor - age between 20-70 year exclusion: - the use of prophylactics soley for the purpose of prophylaxis of urinary tract infection - immune system is weak and inefficient -diabetes mellitus - history recurrent urinary tract infection before admission - surgical procedures at the time of project - anatomic problems and trauma to the genitourinary system weakend immune system disease known hiistory of recurrent urinary tract infection before admission new procedure at the time of implementation anatomic problems and history of trauma to the urinary tract
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary infection. Timepoint: before and after 10 days. Method of measurement: urinalysis and urine culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDoctor .Maryam Valikhani
Arak University of Medical Sciences
Outcome results
None listed